Technical Description
The present invention relates to synthesis of novel sulfonamide derivatives of para amino benzoic acid as selective butrylcholinesterase (BuChE) inhibitors for the treatment of Alzheimer’s disease.
Problems Addressed
- Undesirable Side Effects
- Limitations of Existing Treatments
Tech Features
- Novel Compound
- Inhibits Cholinesterases & BACE-1
- Prevention & Delayed of Disease
- Low IC50 Value
Target Audience
- Healthcare & Medical Sector
- Pharmaceutical Industry
- Biotechnology Firms
- Research and Development
Tech ID: P27-1248 TRL 5 Patent Status: Granted Available For Exclusive and Non-exclusive License
